Literature DB >> 12890620

The genome of bacteriophage phiKMV, a T7-like virus infecting Pseudomonas aeruginosa.

Rob Lavigne1, Maria V Burkal'tseva, Johan Robben, Nina N Sykilinda, Lidia P Kurochkina, Barbara Grymonprez, Bart Jonckx, Victor N Krylov, Vadim V Mesyanzhinov, Guido Volckaert.   

Abstract

The complete DNA sequence of a new lytic T7-like bacteriophage phiKMV is presented. It is the first genome sequence of a member of the Podoviridae that infects Pseudomonas aeruginosa. The linear G + C-rich (62.3%) double-stranded DNA genome of 42,519 bp has direct terminal repeats of 414 bp and contains 48 open reading frames that are all transcribed from the same strand. Despite absence of homology at the DNA level, 11 of the 48 phiKMV-encoded putative proteins show sequence similarity to known T7-type phage proteins. Eighteen open reading frame products have been assigned, including an RNA polymerase, proteins involved in DNA replication, as well as structural, phage maturation, and lysis proteins. Surprisingly, the major capsid protein completely lacks sequence homology to any known protein. Also, the strong virulence toward many clinical P. aeruginosa isolates and a short replication time make phiKMV attractive for phage therapy or a potential source for antimicrobial proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890620     DOI: 10.1016/s0042-6822(03)00123-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  58 in total

1.  BVPaP-3, a T7-like lytic phage of Pseudomonas aeruginosa: its isolation and characterisation.

Authors:  Sangeeta Ahiwale; Divya Prakash; Milind Gajbhiye; Smita Jagdale; Nita Patil; Balu Kapadnis
Journal:  Curr Microbiol       Date:  2012-01-04       Impact factor: 2.188

2.  Genomic analysis of Pseudomonas aeruginosa phages LKD16 and LKA1: establishment of the phiKMV subgroup within the T7 supergroup.

Authors:  Pieter-Jan Ceyssens; Rob Lavigne; Wesley Mattheus; Andrew Chibeu; Kirsten Hertveldt; Jan Mast; Johan Robben; Guido Volckaert
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

3.  The genome of bacteriophage K1F, a T7-like phage that has acquired the ability to replicate on K1 strains of Escherichia coli.

Authors:  Dean Scholl; Carl Merril
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

4.  Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent.

Authors:  Vivek Verma; Kusum Harjai; Sanjay Chhibber
Journal:  Curr Microbiol       Date:  2009-05-30       Impact factor: 2.188

5.  Genomic characterization of Ralstonia solanacearum phage phiRSB1, a T7-like wide-host-range phage.

Authors:  Takeru Kawasaki; Mio Shimizu; Hideki Satsuma; Akiko Fujiwara; Makoto Fujie; Shoji Usami; Takashi Yamada
Journal:  J Bacteriol       Date:  2008-10-24       Impact factor: 3.490

6.  Structural analysis of bacteriophage-encoded peptidoglycan hydrolase domain KMV36C: crystallization and preliminary X-ray diffraction.

Authors:  Kristof Van Hecke; Yves Briers; Rita Derua; Etienne Waelkens; Rob Lavigne; Luc Van Meervelt
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-03-21

7.  The lysis cassette of bacteriophage ϕKMV encodes a signal-arrest-release endolysin and a pinholin.

Authors:  Yves Briers; Liesbet M Peeters; Guido Volckaert; Rob Lavigne
Journal:  Bacteriophage       Date:  2011-01

8.  Characterization of a T7-like lytic bacteriophage (phiSG-JL2) of Salmonella enterica serovar gallinarum biovar gallinarum.

Authors:  Hyuk-Joon Kwon; Sun-Hee Cho; Tae-Eun Kim; Yong-Jin Won; Jihye Jeong; Se Chang Park; Jae-Hong Kim; Han-Sang Yoo; Yong-Ho Park; Sun-Joong Kim
Journal:  Appl Environ Microbiol       Date:  2008-09-26       Impact factor: 4.792

9.  The use of genomic signature distance between bacteriophages and their hosts displays evolutionary relationships and phage growth cycle determination.

Authors:  Patrick Deschavanne; Michael S DuBow; Christophe Regeard
Journal:  Virol J       Date:  2010-07-17       Impact factor: 4.099

10.  Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.

Authors:  Maya Merabishvili; Jean-Paul Pirnay; Gilbert Verbeken; Nina Chanishvili; Marina Tediashvili; Nino Lashkhi; Thea Glonti; Victor Krylov; Jan Mast; Luc Van Parys; Rob Lavigne; Guido Volckaert; Wesley Mattheus; Gunther Verween; Peter De Corte; Thomas Rose; Serge Jennes; Martin Zizi; Daniel De Vos; Mario Vaneechoutte
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.